Samsung Bioepis UK Ltd v Janssen Biotech, Inc.
[2024] EWHC 2442 (Pat)
Claim interpretation should consider claim language, specification, and drawings.
Sycurio v PCI-PAL [2024] EWCA Civ 606
Anticipation requires clear and unmistakable directions; merely asserting a treatment effect is insufficient.
T239/16
Obviousness is a multifactorial question; expectation of success is a key factor but needs to be balanced against other factors.
Actavis v ICOS [2019] UKSC 15
Patent invalid for obviousness.
The Sands Slides, showing positive results from the UNIFI trial's induction phase, created a strong expectation of success in the maintenance phase, rendering the patent obvious. The Ochsenkühn prior art, while showing some positive results, lacked the necessary strength to demonstrate anticipation or obviousness.
Anticipation and obviousness attacks over Ochsenkühn's work failed.
The Ochsenkühn Abstract and Poster, while showing some improvement in UC patients, did not demonstrate efficacy to the required standard and did not create a reasonable expectation of success.
[2024] EWHC 2442 (Pat)
[2024] EWHC 2524 (Pat)
[2024] EWHC 2567 (Pat)
[2023] EWCA Civ 880
[2024] EWHC 796 (Pat)